Author
Listed:
- Ana Ruigómez
(Centro Español de Investigación Farmacoepidemiológica (CEIFE))
- Estel Plana
(RTI Health Solutions)
- Alicia Gilsenan
(RTI Health Solutions)
- Joan Fortuny
(RTI Health Solutions)
- Miguel Cainzos-Achirica
(Houston Methodist DeBakey Heart and Vascular Center
Houston Methodist)
- Robert W. V. Flynn
(University of Dundee)
- Thomas M. MacDonald
(University of Dundee)
- Luis Garcia-Rodriguez
(Centro Español de Investigación Farmacoepidemiológica (CEIFE))
- Ryan Ziemiecki
(RTI Health Solutions)
- Elizabeth B. Andrews
(RTI Health Solutions)
Abstract
Introduction A multinational post-authorization safety study assessed cardiovascular safety in initiators of prucalopride for chronic constipation compared with a matched cohort of polyethylene glycol 3350 initiators. The primary safety outcome was major adverse cardiovascular events (MACE), a composite of hospitalization for acute myocardial infarction, stroke, or in-hospital cardiovascular death. We report the validation process for MACE endpoints in United Kingdom (UK) data sources: Clinical Practice Research Datalink (CPRD GOLD), The Health Improvement Network (THIN), and the Information Services Division (ISD) Scotland. Methods Modified electronic algorithms from prior research identified potential MACE cases. Validation followed a common protocol, adapted for each database, with all information anonymized: (1) direct confirmation via linkage to hospital records (CPRD GOLD); (2) requests for additional clinical information through questionnaires (CPRD GOLD), free-text (THIN), or abstraction of hospital records (ISD); (3) manual review of electronic records of potential events retrieved by the algorithm (CPRD GOLD/THIN); and (4) event adjudication by three clinicians, blinded to exposure, for all remaining events. Results Electronic algorithms identified 260 potential MACE cases: 38 confirmed via linkage to hospital records (CPRD GOLD), 56 ruled out as non-cardiovascular death cases (THIN), and three unavailable for review (ISD), leaving 163 potential cases. After manual review with additional information (steps 2 and 3), 45 were considered noncases (CPRD GOLD/THIN). Upon final adjudication (step 4), remaining potential events were adjudicated as definite (n = 62), probable (n = 10), possible (n = 13), or noncases (n = 33). Conclusions Given the limitations of relying solely on computer algorithms to identify cardiovascular outcomes, validation with clinical review is essential to guide interpretation.
Suggested Citation
Ana Ruigómez & Estel Plana & Alicia Gilsenan & Joan Fortuny & Miguel Cainzos-Achirica & Robert W. V. Flynn & Thomas M. MacDonald & Luis Garcia-Rodriguez & Ryan Ziemiecki & Elizabeth B. Andrews, 2021.
"Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride,"
Drug Safety, Springer, vol. 44(5), pages 541-551, May.
Handle:
RePEc:spr:drugsa:v:44:y:2021:i:5:d:10.1007_s40264-021-01044-4
DOI: 10.1007/s40264-021-01044-4
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:44:y:2021:i:5:d:10.1007_s40264-021-01044-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.